• Investors
  • Contact
  • Privacy Policy
  • WORLD GLAUCOMA
    CONGRESS 2023

    BREAKFAST SYMPOSIUM

    Join Ike Ahmed, MD in Rome to discuss the ins and outs of canaloplasty with the new iTrack™ Advance.

    Join MIGS pioneer Ike Ahmed, MD and a global panel from the UK, Germany, Spain, Italy and Brazil on Friday morning during the World Glaucoma Congress, WGC to discuss their treatment algorithm for canaloplasty with the new iTrack™ Advance. The world’s only illuminated canaloplasty microcatheter, iTrack™ Advance is lighting the way in stent-free, tissue-sparing MIGS

    Friday, June 30

    La Nuvola Convention Center, Room B

    7.30 — 8.30am

    Moderator:

    Ike Ahmed (Canada) 


    Faculty:

    Andrew Tatham (UK)

    Jose Maria Martinez de la Casa (Spain)

    Neeru Vallabh (UK)

    Karsten Klabe (Germany)

    Ticiana de Francesco (Brazil)

    Antonio Fea (Italy)

    Norbert Koerber (Germany)

    Karl Mercieca (Germany)

    Note: This symposium is affiliated with the official program of the WGC 2023.

    REGISTER FOR BREAKFAST WITH IKE AHMEDMD

    MEET THE EXPERTS

    Discuss the utility of iTrack™ Advance in the glaucoma treatment paradigm with a panel of canaloplasty surgeons, Exhibit #D148

    Make sure to stop by the Nova Eye exhibit #D148 on Thursday and Friday to spend some time with a canaloplasty expert to discuss their surgical pearls and treatment tips for the new iTrack™ Advance. Refreshments available. 

    Thursday, June 29

    Meet the Expert

    12:30pm — Nova Eye Exhibit #D148

    Jose Maria Martinez de la Casa (Spain), Antonio Fea (Italy), Karl Mercieca (Germany), Joe Panarelli (USA), Paul I. Singh (USA)

    3:00pm — Nova Eye Exhibit #D148

    Ike Ahmed (Canada), Karsten Klabe (Germany), Ticiana de Francesco (Brazil), George Tanaka (USA), Joe Panarelli (USA)

    Note: These sessions are not affiliated with the official program of the WGC 2023.

    Friday, June 30

    Meet the Expert

    12:30pm — Nova Eye Exhibit #D148

    Jose Maria Martinez de la Casa (Spain), Karl Mercieca (Germany), Andrew Tatham (UK), Paul I. Singh (USA), Joe Panarelli (USA

    3:00pm — Nova Eye Exhibit #D148

    Jose Maria Martinez de la Casa (Spain), George Tanaka (USA), Ticiana de Francesco (Brazil), Joe Panarelli (USA)

    Note: These sessions are not affiliated with the official program of the WGC 2023.

    Visit us at Exhibit #D148 to learn about the new iTrack™ Advance for canaloplasty – and take part in a hands-on demo.

    The iTrack™ Advance is arguably the world’s most advanced canaloplasty device. Built on the tried and tested iTrack™ platform, which has been used in more than 120,000 canaloplasty procedures globally, the new iTrack™ Advance combines the world’s only illuminated canaloplasty microcatheter with an easy-to-use handheld injector and custom cannula. But don’t just take our word for it. Visit exhibit #D148 to take part in a hands-on demo. 

    Canaloplasty on the podium at the World Glaucoma Congress 

    Canaloplasty will feature in a number of posters at the WGC 2023. Please see the summary below and review the official WGC program for more details.

    Posters

    Global Longitudinal Data Registry on the Role of Canaloplasty for Treatment of Glaucoma - One Year Results

    David Lubeck (USA); Nathan Kerr (Australia); Keith Barton (UK); Iqbal “Ike” Ahmed (Canada

    Endothelial Cell Density and Loss Following Ab-Interno Canaloplasty in Patients with Mild-Moderate Glaucoma as Compared to Severe Glaucoma

    David Lubeck (USA); Robert Noecker (USA)

    24-Month Evaluation of Endothelial Cell Density and Loss Following Ab-Interno Canaloplasty

    David Lubeck (USA); Robert Noecker (USA)

    6-Year Efficacy and Safety of iTrack Ab-interno Canaloplasty as a Standalone Procedure and Combined with Cataract Surgery in Primary Open-Angle Glaucoma

    Norbert Körber (Germany); Simon Ondrejka (Germany)

    Contact us

    Register for updates

    This website uses cookies to ensure you get the best experience on our website.
    The cookies do not store any personalised information. Learn More